Market Closed -
Japan Exchange
02:00:00 2024-04-25 am EDT
5-day change
1st Jan Change
45
JPY
-2.17%
-4.26%
+4.65%
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 2021
May 12, 2021 at 02:00 am EDT
MEDINET Co., Ltd. provided earnings guidance for the year ending September 2021. For the year, the company expects net sales of JPY 810 million, operating loss of JPY 1,775 million, loss of JPY 1,768 million and basic loss per share of JPY 11.00.
MEDINET Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending September 30, 2024
Nov. 10
CI
Kokoro Mill Co., Ltd announced that it has received ¥270 million in funding from MEDINET Co., Ltd., Macnica, Inc., Nahato Inc. and other investors.
23-09-18
CI
Kokoro Mill Co., Ltd announced that it expects to receive funding from MEDINET Co., Ltd.
23-08-27
CI
MEDINET Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending September 30, 2023
23-07-31
CI
MEDINET Co., Ltd. announced that it has received ¥33.075 million in funding from Macquarie Bank Limited, Investment Arm
23-03-05
CI
MEDINET Co., Ltd. announced that it expects to receive ¥33.075 million in funding from Macquarie Bank Limited, Investment Arm
23-02-16
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023
23-02-09
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2023
22-11-11
CI
Medinet Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022
22-08-10
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022
22-05-12
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022
22-02-10
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2022
21-11-12
CI
MEDINET Co., Ltd. announced that it has received ¥22.44 million in funding from Macquarie Bank Limited, Investment Arm
21-08-31
CI
MEDINET Co., Ltd. announced that it expects to receive ¥22.44 million in funding from Macquarie Bank Limited, Investment Arm
21-08-15
CI
MEDINET Co., Ltd. Reports Earnings Results for the Third Quarter Ended June 2021
21-08-11
CI
Medinet Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2021
21-08-11
CI
MEDINET Co., Ltd. Reports Earnings Results for the Second Quarter Ended March 2021
21-05-12
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 2021
21-05-12
CI
MEDINET Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2020
21-02-05
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2021
21-02-05
CI
Medinet Co., Ltd. Reports Consolidated Earnings Results for the Year Ended September 30, 2020
20-11-13
CI
MEDINET Co., Ltd. Provides Earnings Guidance for the Year Ending September 30, 2021
20-11-13
CI
MEDINET Co., Ltd.(TSE:2370) added to S&P Global BMI Index
20-09-21
CI
MEDINET Co., Ltd. announced that it has received ¥24.13 million in funding from Macquarie Bank Limited, Investment Arm
20-09-06
CI
MEDINET Co., Ltd. announced that it expects to receive ¥24.13 million in funding from Macquarie Bank Limited, Investment Arm
20-08-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
More about the company
1st Jan change
Capi.
+4.65% 76M +4.09% 43.84B +46.40% 41.25B +9.45% 41.68B -10.92% 27.04B +9.32% 25.53B -24.87% 18.18B +29.70% 12.29B +1.28% 12.29B +7.78% 11.15B
Other Biotechnology & Medical Research
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
MEDINET CO., LTD. 
